Myeloid‐Derived Suppressor Cells in Cancer: Mechanistic Insights and Targeted Therapeutic Innovations

Myeloid‐Derived Suppressor Cells in Cancer: Mechanistic Insights and Targeted Therapeutic Innovations

ABSTRACT Myeloid‐derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells that expand aberrantly in cancer and exhibit potent immunosuppressive properties. They contribute to tumor progression through both immunological and nonimmunological mechanisms. Immunologicall...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tianying Hu, Jianxue Zhai, Zhanda Yang, Jiajia Peng, Chuxuan Wang, Xinyao Liu, Yawen Li, Jiaqi Yao, Fengxi Chen, Haixia Li, Taixue An, Zongcai Liu, Haifang Wang
Format:	Article
Language:	English
Published:	Wiley 2025-06-01
Series:	MedComm
Subjects:	myeloid‐derived suppressor cells (MDSCs) MDSC phenotype tumor microenvironment (TME) tumor‐promoting mechanisms biomarker potential therapeutic strategy
Online Access:	https://doi.org/10.1002/mco2.70231
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Interactions between glioblastoma and myeloid cells
by: Yuting Li, et al.
Published: (2025-06-01)

The role of myeloid-derived suppressor cells in the pathogenesis of rheumatoid arthritis; anti- or pro-inflammatory cells?
by: Misagh Rajabinejad, et al.
Published: (2019-12-01)

The role of myeloid-derived suppressor cells in children
by: Jordan Brauner, et al.
Published: (2025-02-01)

Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma by facilitating PPARα-mediated fatty acid oxidation
by: Chunxiao Li, et al.
Published: (2025-01-01)

Recruitment of Polymorphonuclear Myeloid-Derived Suppressor Cells During Cryptococcus neoformans Infection
by: JOYCE C. GUIMARÃES-DE-OLIVEIRA, et al.
Published: (2025-04-01)

Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy
by: Shuyan He, et al.
Published: (2025-01-01)

Effect of pregnancy-specific β1-glycoprotein on myeloid-derived suppressor cell differentiation
by: V. P. Timganova, et al.
Published: (2023-06-01)

Impact of Microparticle Transarterial Chemoembolization (mTACE) on myeloid‐derived suppressor cell subtypes in hepatocellular carcinoma: Clinical correlations and therapeutic implications
by: Yuanxun Yue, et al.
Published: (2024-09-01)

Myeloid-Derived Suppressor Cells in Some Oncohematological Diseases
by: AV Ponomarev
Published: (2017-01-01)

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
by: Antonino Glaviano, et al.
Published: (2025-01-01)

Myeloid-Derived Suppressor Cells in Bladder Cancer: An Emerging Target
by: Clément Klein, et al.
Published: (2024-10-01)

Pam2 lipopeptides enhance the immunosuppressive activity of monocytic myeloid-derived suppressor cells by STAT3 signal in chronic inflammation
by: Xiaoxia Zhan, et al.
Published: (2022-02-01)

A novel method for isolation of tumor infiltrating myeloid-derived suppressor cells from human lung tumor tissue
by: Marta Piqueras-Nebot, et al.
Published: (2025-04-01)

EVA1B facilitates esophageal squamous carcinoma progression and recruitment of immunosuppressive myeloid-derived suppressor cells in the tumor microenvironment
by: Tian Xia, et al.
Published: (2024-12-01)

Decreased melanoma CSF-1 secretion by Cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progression
by: Iris Wyrobnik, et al.
Published: (2023-12-01)

The accumulation of myeloid‐derived suppressor cells participates in abdominal infection‐induced tumor progression through the PD‐L1/PD‐1 axis
by: Yiding Wang, et al.
Published: (2025-05-01)

Impact of Reduction in Myeloid‐derived Suppressor Cells by Wilms’ Tumor 1‐targeted Dendritic Cell Vaccines on Clinical Outcomes in Acute Leukemia Patients
by: Masahiro Ogasawara, et al.
Published: (2025-06-01)

Deletion of gasdermin D promotes granulocytic myeloid-derived suppressor cell differentiation by decreased release of mitochondrial DNA to promote tumor escape
by: Min Gu, et al.
Published: (2025-07-01)

Myeloid-derived suppressor cells in secondary sepsis: Is there an association with lethal outcome?
by: Udovičić Ivo, et al.
Published: (2020-01-01)

MiR‐486 promotes proliferation and suppresses apoptosis in myeloid cells by targeting Cebpa in vitro
by: Jingwei Jiang, et al.
Published: (2018-09-01)

Targeting Myeloid-Derived Suppressor Cells via Dual-Antibody Fluorescent Nanodiamond Conjugate
by: Colin D. Angell, et al.
Published: (2024-09-01)

Modulating the CXCR2 Signaling Axis Using Engineered Chemokine Fusion Proteins to Disrupt Myeloid Cell Infiltration in Pancreatic Cancer
by: Benjamin N. Christopher, et al.
Published: (2025-04-01)

Tumor microenvironment in primary central nervous system lymphoma (PCNSL)
by: Qiqi Jin, et al.
Published: (2024-12-01)

Aging modulates the immunosuppressive, polarizing and metabolic functions of blood-derived myeloid-derived suppressor cells (MDSCs)
by: Emma Keltsch, et al.
Published: (2025-07-01)

Single-cell transcriptomic analysis identified resistant MDSCs and a stress-tolerant gene co-expression network as common MDSC features across multiple disease settings
by: Tianmeng Chen, et al.
Published: (2025-04-01)

Tumor suppressor genes in the tumor microenvironment
by: Bahareh Tabanifar, et al.
Published: (2025-03-01)

The Recruitment and Immune Suppression Mechanisms of Myeloid‐Derived Suppressor Cells and Their Impact on Bone Metastatic Cancer
by: Chengyuan Li, et al.
Published: (2025-02-01)

Decreased number of myeloid-derived suppressor cells in the placental trophoblast of gestational diabetes mellitus. Possible role of leptin
by: Malika Tami, et al.
Published: (2025-05-01)

Immunosuppressive role of CD11b+CD33+HLA‐DR− myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia
by: Shin Young Hyun, et al.
Published: (2020-10-01)

Myeloid-derived suppressor-like cells - does their frequency change in patients with different stages of CRC?
by: Brčerević Irina, et al.
Published: (2023-01-01)

The role of peripheral innate immune cells in Alzheimer’s disease progression
by: Yanchun Cao, et al.
Published: (2025-07-01)

Galectin‐9 and myeloid‐derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia
by: Xierenguli Alimu, et al.
Published: (2023-05-01)

CD16 and Siglec expression refine the phenotypic heterogeneity of steady-state myeloid-derived suppressor cells
by: Chris D. St. Laurent, et al.
Published: (2025-06-01)

Platelet‐activating factor: a potential therapeutic target to improve cancer immunotherapy
by: Qi Yan, et al.
Published: (2025-01-01)

Circulating myeloid-derived suppressor cell load and disease severity are associated to an enhanced oligodendroglial production in a murine model of multiple sclerosis
by: Mari Paz Serrano-Regal, et al.
Published: (2025-06-01)

Abnormal proportions and functions of myeloid-derived suppressor cells in peripheral blood of patients with diffuse large B-cell lymphoma
by: Jingru Liu, et al.
Published: (2025-04-01)

A potential tumor suppressor role of PLK2 in glioblastoma
by: Xiangping Xia, et al.
Published: (2025-05-01)

Th17/Treg balance is regulated by myeloid‐derived suppressor cells in experimental autoimmune myocarditis
by: Xin Xiong, et al.
Published: (2023-06-01)

CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy
by: Ayush Pant, et al.
Published: (2024-12-01)

Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancer
by: Nilesh U. Deshpande, et al.
Published: (2025-06-01)